Both ART and infertility raise birth defects risk

Article

Both the use of assisted reproduction technology and infertility are associated with increased risk of birth defects.

Although assisted reproduction has been associated with an increased risk of birth defects, the risk varies among methods.

Use of clomiphene citrate as a single agent at home was associated with a higher rate of birth defects than clinically managed induction of ovulation using any of several drugs.

Assisted reproductive technologies (ART) raise the risk for birth defects by about 28%-but so does infertility, a large observational study from Australia reports.

Researchers reviewed almost 309,000 births for birth defects. Of these, 6,163 involved ART. The multivariate adjusted odds ratio (OR) of a birth defect diagnosed before age 5 years in a child conceived through ART was 1.28 versus 1 from unassisted conception (95% confidence interval, 1.16-1.41).

For in vitro fertilization (IVF) alone, the OR after multivariate adjustment was 1.07, which was statistically insignificant, whereas that for intracytoplasmic sperm injection (ICSI) remained significant at 1.57 after adjustment.

Compared with births from spontaneous conception in fertile women, births from spontaneous conception in women who used ART with a previous pregnancy also had increased overall risk of any birth defect, even after adjustment for confounders (OR, 1.25) Further, a history of infertility without ART treatment was associated with an adjusted OR of 1.29.

Compared with clinically managed induction of ovulation with the use of any of several drugs, the use of clomiphene citrate as a single agent at home was associated with an increased risk of birth defects, as was using fresh- versus frozen-embryo cycles of IVF or ICSI.

Although significant associations between assisted conception and birth defects existed for singleton births, multiple births remained unaffected. The research was published in the New England Journal of Medicine (2012;366[19]:1803-1813).

Read other articles in this issue of Special Delivery

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.